Prednisolone NDC 60722-5011

NDC codes

FDA NDC Directory

Product NDC (as listed)60722-5011Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60722-5011Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60722-5011-0	60722501100	100 TABLET in 1 BOTTLE (60722-5011-0)Marketed from Sep 1, 2024
60722-5011-1	60722501101	1000 TABLET in 1 BOTTLE (60722-5011-1)Marketed from Sep 1, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Prednisolone
Generic name (nonproprietary): prednisolone
Active ingredients: Prednisolone — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Zhejiang Xianju Pharmaceutical Co., Ltd.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218083
Marketing start: Sep 1, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 60722-5011_da9dfcf4-1631-4923-9536-72c27fc0b307SPL ID da9dfcf4-1631-4923-9536-72c27fc0b307SPL set ID 52e6e21d-94b8-41a0-8d13-371c0e66bceeRxCUI 198142UNII 9PHQ9Y1OLMUPC 0360722501101, 0360722501118
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460722501100 followed by a unit qualifier and the quantity

Package 60722-5011-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 5, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE 1. Endocrine disorders. Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer 2. Rheumatic disorders. As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: Psoriatic arthritis Rheumatoid arthritis; including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) Ankylosing spondy…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 218083

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218083
Product	Strength	Form · route	Labeler	Product NDC
Prednisolone	Prednisolone 5 mg/1	TabletOral	Hisun Pharmaceuticals USA, Inc.	42658-160